Steris (STE) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts STE Hot Sheet
Price: $224.59 --0%
Revenue Growth %: +6.8%
Financial Fact:
Restructuring expenses: -56K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +6.8%
Financial Fact:
Restructuring expenses: -56K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q2 EPS of $0.80, $0.03 better than the analyst estimate of $0.77. Revenue for the quarter came in at $489.9 million versus the consensus estimate of $488.66 million.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi turns more bullish on trucking stocks
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Guggenheim Reiterates Buy Rating on Oracle (ORCL)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
